NCT07112521View on ClinicalTrials.gov

tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Breast Cancer SurvivorObesity, Overweight
Interventions
DEVICE

active tDCS

The anodal electrode will be placed over the left DLPFC (F3), and the cathodal electrode will be placed over the right supraorbital area (FP2). The current will be gradually ramped up to 2mA over 30 seconds, held constant at 2mA for 29 minutes, and then gradually ramped down to 0mA over the final 30 seconds.

DEVICE

sham tDCS

The anodal electrode will be placed over the left DLPFC (F3), and the cathodal electrode will be placed over the right supraorbital area (FP2). The current will be initially ramped up to 2mA over 30 seconds and immediately ramped back down to 0mA.

Trial Locations (1)

00200

RECRUITING

Department of Psychology, Faculty of Medicine, University of Helsinki, Helsinki

All Listed Sponsors
lead

University of Helsinki

OTHER

NCT07112521 - tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment | Biotech Hunter | Biotech Hunter